AquaBounty Raises $2.25M in Dilutive Preferred Stock Offering Amid Financial Distress
AQB sits 57% above its 52-week low of $0.7.
Summary
AquaBounty Technologies raised $2.25 million through a private placement of Series B Convertible Preferred Stock. This financing is critical for working capital, as the company previously reported a Q1 net loss and a 'going concern' warning due to critically low cash. The offering is highly dilutive, with the preferred shares convertible into up to 2.18 million common shares, representing a substantial increase to the current share count. This follows a recent 8-K filing and shareholder approval for a reverse stock split, underscoring the company's ongoing financial challenges.
At the time of this announcement, AQB was trading at $1.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $0.70 to $2.95. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Wiseek News.